Bram De Wilde

Citado por

	Todos	Desde 2020
Citações	3976	2303
Índice h	22	18
Índice i10	31	27

500

250

125

375

2012201320142015201620172018201920202021202220232024202511 123 169 196 256 266 259 349 373 481 442 444 467 90

Acesso público

Ver tudo

33 artigos

5 artigos

disponível

não disponível

Com base em autorizações de financiamento

Coautores

Katleen De Preterfull research professor, Ghent UniversityEmail confirmado em ugent.be
Jo Vandesompeleprofessor in functional cancer genomics and applied bioinformaticsEmail confirmado em ugent.be
Ruben Van PaemelUniversiteit GentEmail confirmado em UGent.be
Björn MentenCenter for Medical Genetics, Department of Biomolecular Medicine,Ghent UniversityEmail confirmado em ugent.be
Anneleen DecockPostdoctoral Researcher, Ghent UniversityEmail confirmado em ugent.be
Nico CallewaertProfessor, Ghent University. Associate director, VIB-UGent Center for Medical BiotechnologyEmail confirmado em vib-ugent.be
Jo Van DorpeEmail confirmado em telenet.be
Pieter Mestdaghpostdoctoral fellow, Ghent UniversityEmail confirmado em ugent.be
Gaelle PierronPhD. Responsable Adjoint Unité Génétique Somatique Institut Curie ParisEmail confirmado em curie.fr
Sven LindnerUniversity Hospital EssenEmail confirmado em ruhr-uni-bochum.de
Wim Van CriekingeProfessor Bioinformatics, University of GhentEmail confirmado em ugent.be
Maté OngenaertPrincipal Scientist II Computational Biology at Johnson & Johnson Innovative MedicineEmail confirmado em its.jnj.com
Tommy MartinssonProfessor of Cancer Genetics, University of Gothenburg, Göteborg, SwedenEmail confirmado em gu.se
Jan Molenaar-Email confirmado em prinsesmaximacentrum.nl
De Baere ElfrideProfessor, Center for Medical Genetics, Department of Biomolecular Medicine, Ghent UniversityEmail confirmado em ugent.be
gian paolo toniniNeuroblastoma Laboratory, Pediatric Research Institute, Padova, ItalyEmail confirmado em irpcds.org
Stallings RLEmeritus Professor of Cancer Genetics, RCSI University of Medicine and Health Sciences, IrelandEmail confirmado em rcsi.ie
Dieter DeforceUniversity Gent, Ghent UniversityEmail confirmado em ugent.be
Joachim De Schrijver, PhDBioinformatics @ Agilent TechnologiesEmail confirmado em Agilent.com
Lieven ClementAssociate Professor in Statistical Genomics, Ghent UniversityEmail confirmado em ugent.be

Seguir

Bram De Wilde

Ugent

Email confirmado em ugent.be - Página inicial


Título Ordenar por citações Ordenar por ano Ordenar por título	Citado por Citado por	Ano
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer M Peifer, L Fernández-Cuesta, ML Sos, J George, D Seidel, LH Kasper, ... Nature genetics 44 (10), 1104-1110, 2012	1550	2012
Telomerase activation by genomic rearrangements in high-risk neuroblastoma M Peifer, F Hertwig, F Roels, D Dreidax, M Gartlgruber, R Menon, ... Nature 526 (7575), 700-704, 2015	663	2015
A mechanistic classification of clinical phenotypes in neuroblastoma S Ackermann, M Cartolano, B Hero, A Welte, Y Kahlert, A Roderwieser, ... Science 362 (6419), 1165-1170, 2018	336	2018
Emergence of New ALK Mutations at Relapse of Neuroblastoma G Schleiermacher, N Javanmardi, V Bernard, Q Leroy, J Cappo, ... Journal of Clinical Oncology 32 (25), 2727-2734, 2014	242	2014
Targeted expression of mutated ALK induces neuroblastoma in transgenic mice LC Heukamp, T Thor, A Schramm, K De Preter, C Kumps, B De Wilde, ... Science translational medicine 4 (141), 141ra91-141ra91, 2012	210	2012
Shallow whole genome sequencing on circulating cell-free DNA allows reliable noninvasive copy-number profiling in neuroblastoma patients N Van Roy, M Van Der Linden, B Menten, A Dheedene, C Vandeputte, ... Clinical Cancer Research 23 (20), 6305-6314, 2017	131	2017
Accelerating drug development for neuroblastoma: summary of the second neuroblastoma drug development strategy forum from innovative therapies for children with cancer and … L Moreno, G Barone, SG DuBois, J Molenaar, M Fischer, J Schulte, ... European Journal of Cancer 136, 52-68, 2020	73	2020
The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review R Van Paemel, R Vlug, K De Preter, N Van Roy, F Speleman, L Willems, ... European journal of pediatrics 179, 191-202, 2020	65	2020
Practical tools to implement massive parallel pyrosequencing of PCR products in next generation molecular diagnostics K De Leeneer, J De Schrijver, L Clement, M Baetens, S Lefever, ... PLoS One 6 (9), e25531, 2011	52	2011
Massively parallel sequencing for early molecular diagnosis in Leber congenital amaurosis F Coppieters, B De Wilde, S Lefever, E De Meester, N De Rocker, ... Genetics in medicine 14 (6), 576-585, 2012	50	2012
Minimally invasive classification of paediatric solid tumours using reduced representation bisulphite sequencing of cell-free DNA: a proof-of-principle study R Van Paemel, A De Koker, C Vandeputte, L van Zogchel, T Lammens, ... Epigenetics 16 (2), 196-208, 2021	47	2021
Genome-wide study of the effect of blood collection tubes on the cell-free DNA methylome R Van Paemel, A De Koker, C Caggiano, A Morlion, P Mestdagh, ... Epigenetics 16 (7), 797-807, 2021	34	2021
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition C Nunes, L Depestel, L Mus, KM Keller, L Delhaye, A Louwagie, M Rishfi, ... Science advances 8 (28), eabn1382, 2022	33	2022
ALK positively regulates MYCN activity through repression of HBP1 expression S Claeys, G Denecker, K Durinck, B Decaesteker, LM Mus, S Loontiens, ... Oncogene 38 (15), 2690-2705, 2019	33	2019
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma A Decock, M Ongenaert, R Cannoodt, K Verniers, B De Wilde, G Laureys, ... Oncotarget 7 (2), 1960, 2015	32	2015
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM H Peterziel, N Jamaladdin, D ElHarouni, XF Gerloff, S Herter, P Fiesel, ... NPJ precision oncology 6 (1), 94, 2022	29	2022
Stage 4S neuroblastoma tumors show a characteristic DNA methylation portrait A Decock, M Ongenaert, B De Wilde, B Brichard, R Noguera, F Speleman, ... Epigenetics 11 (10), 761-771, 2016	29	2016
Target enrichment using parallel nanoliter quantitative PCR amplification B De Wilde, S Lefever, W Dong, J Dunne, S Husain, S Derveaux, ... BMC genomics 15, 1-14, 2014	28	2014
The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples R Van Paemel, C Vandeputte, L Raman, J Van Thorre, L Willems, ... European Journal of Cancer 160, 12-23, 2022	25	2022
Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: a report from the Innovative Therapies for Children with Cancer (ITCC) consortium A Rubio-San-Simón, N André, MG Cefalo, I Aerts, A Castañeda, ... European Journal of Cancer 141, 82-91, 2020	25	2020

O sistema não pode efectuar a operação agora. Tente mais tarde.

Artigos 1–20

Citações por ano

Citações duplicadas

Citações unidas

Adicionar coautoresCoautores

Seguir

Citado por

Coautores